Insulin-like growth factor-I (IGF-I) has mitogenic and antiapoptotic effects on breast cancer cells. Epidemiologic studies have shown that high plasma levels of IGF-I and low levels of IGF binding protein (BP)-3 are associated with increased risk of breast cancer in premenopausal women. The actions
Insulin-like growth factor levels in cord blood, birth weight and breast cancer risk
โ Scribed by Lagiou, P; Hsieh, C C; Lipworth, L; Samoli, E; Okulicz, W; Troisi, R; Xu, B; Hall, P; Ekbom, A; Adami, H O
- Book ID
- 110000048
- Publisher
- Nature Publishing Group
- Year
- 2009
- Tongue
- English
- Weight
- 110 KB
- Volume
- 100
- Category
- Article
- ISSN
- 0007-0920
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
## Abstract Increased levels of insulinโlike growth factor I (IGFโI) may directly stimulate breast cell proliferation and promote growth and survival of transformed cells. Higher levels of IGFโI have been associated with increased risk of premenopausal breast cancer but not postmenopausal breast ca
In the current study the authors have investigated whether human primary breast cancer specimens contain insulin-like growth factor-1 (IGF-1) receptors (IGF-1-R) or IGF-1-like activities. Simultaneously, epidermal growth factor (EGF) receptors (EGF-R) and cytosolic estrogen receptor (ER), progestero
## Abstract Insulinโlike growth factor (IGF)โI, a mitogenic and antiโapoptotic peptide, has been implicated in the development of several cancers. We hypothesized that high circulating IGFโI concentrations may be associated with an increased risk of ovarian cancer. A caseโcontrol study was nested w
## Abstract The evidence that high circulating levels of insulinโlike growth factorโI (IGFโI) are associated with an increased risk of breast cancer among premenopausal women lends credence to the hypothesis that genetic polymorphisms in the __IGFโI__ gene may be involved in the disease. A populati